Clin2
NCT07176143Possibly a fitNot yet recruiting

Stem cell injection for severe uterine scarring and infertility

Intrauterine Adhesions

Part of Women’s health & pregnancy clinical trials.

This trial tests if injecting a patient's own bone marrow stem cells into the uterus can help grow the lining in women with severe scarring and infertility. It might offer a new option for those who have not been able to have a frozen embryo transfer because their uterine lining stays too thin.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
60 people
Ages
20 years to 38 years
Study type
Interventional

Who can take part

  • You are between 20 and 38 years old.
  • Your body mass index (BMI) is between 18 and 27.
  • You have regular periods (every 27 to 35 days) for at least 6 months.
  • You have been diagnosed with severe uterine scarring (intrauterine adhesions) and had surgery for it.
  • You have at least two high-quality frozen embryos (day 5 or 6).
  • You have had at least one frozen embryo transfer cancelled because your uterine lining was too thin (less than 6 mm).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06896747Recruiting· Phase 1/Phase 2
Stem cell therapy for thin uterine lining

This trial tests a new treatment using stem cell particles (exosomes) to help rebuild the lining of the womb in women whose lining is too thin after surgery for scar tissue. It may improve chances of success with IVF.

Xi'an, Shaanxi
NCT07611474Recruiting
Testing a treatment to prevent uterine scar tissue after surgery

This trial tests a new product designed to prevent scar tissue (adhesions) from forming inside the uterus after surgery. If you have uterine scar tissue causing fertility problems or irregular periods, this study may help determine if the treatment is safe and effective.

Changsha, Hunan
NCT07536971Not yet recruiting
i-PRF Treatment for Severe Uterine Scarring and Fertility

This study tests a new treatment called i-PRF (a special growth-factor preparation made from your blood) injected into the uterus to help heal severe internal scarring (adhesions) that can prevent pregnancy. The goal is to restore the uterine lining so you can conceive naturally after surgery.

Beijing
NCT07230600Recruiting· Phase 1
Stem cell therapy for thin uterine lining or scarring

This trial tests a new treatment for people with a thin uterine lining or uterine scarring that hasn't responded to other stem cell therapy. It might help improve the lining so pregnancy is possible.

Nanjing, Jiangsu
NCT05343572Recruiting· Early Phase 1
Stem cell treatment to improve abnormal uterine lining

This early-phase study tests whether mobilized stem cells from bone marrow can help women with certain abnormal uterine lining problems become healthier and possibly improve fertility. It’s aimed at people who are not pregnant and meet specific diagnoses and test results.

Orange, Connecticut
NCT07101484Enrolling by invitation
Study of a new liquid dressing for moderate-severe uterine scarring

This trial tests a new liquid dressing made from human cells to see if it is safe and helps heal moderate to severe uterine scarring (intrauterine adhesions) in women who want to have children. Participants will receive the dressing during a hysteroscopic procedure.

Nanjing, Jiangsu

Hear when a new Intrauterine Adhesions trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.